documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

12 rows where docket_id = "FDA-2009-N-0374" sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: subtype, posted_date, posted_month, comment_start_date, last_modified, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

document_type 2

posted_year 1

agency_id 1

id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2009-N-0374-0016 FDA None FDA-2009-N-0374 Ellen Frank, Director Division of Public Affairs - "Educating the Public On the Phase-Out of Epinephrine CFC Inhalers" [Public Workshop, September 25, 2009] - Testimony Other TS-Testimony 2009-12-14T05:00:00Z 2009 12 2009-12-14T05:00:00Z   2013-07-27T23:01:22Z   0 0 0900006480a62271
FDA-2009-N-0374-0014 FDA None FDA-2009-N-0374 Nancy Sander, Allergy and Asthma Network, Mothers of Asthmatics (AANMA) "OTC Bronchodilator MDIS: Patient/Parent Perspectives" - [Public Workshop, September 25, 2009] - Testimony Other TS-Testimony 2009-12-02T05:00:00Z 2009 12 2009-12-02T05:00:00Z   2013-07-27T23:01:22Z   0 0 0900006480a6226d
FDA-2009-N-0374-0015 FDA None FDA-2009-N-0374 Charlotte W. Collins, J.D., Asthma and Allergy Foundation of America (AAFA) - [Public Workshop, September 25, 2009] - Testimony Other TS-Testimony 2009-12-02T05:00:00Z 2009 12 2009-12-02T05:00:00Z   2013-07-27T23:01:22Z   0 0 0900006480a6226f
FDA-2009-N-0374-0012 FDA None FDA-2009-N-0374 Educating the Public About Removal of Essential-Use Designation for Epinephrine; Public Workshop, ("Phase Out of CFC-Propelled Epinephrine Inhalation Aerosol"), September 25, 2009 - Transcript Other TR-Transcript 2009-11-27T05:00:00Z 2009 11 2009-11-27T05:00:00Z   2009-11-27T17:24:26Z   0 0 0900006480a5f2ca
FDA-2009-N-0374-0008 FDA None FDA-2009-N-0374 Steve Campbell, Esq., "Epinephrine Use and Communication Plan" [Public Workshop, September 25, 2009] - Testimony Other TS-Testimony 2009-10-20T04:00:00Z 2009 10 2009-10-20T04:00:00Z   2013-08-11T03:04:29Z   0 0 0900006480a36820
FDA-2009-N-0374-0007 FDA None FDA-2009-N-0374 Marcus M. Reidenberg, MD, "Perspective on Underserved Populations: Is the Need for Prescriptions a Barrier to Care?" [Public Workshop, September 25, 2009] - Testimony Other TS-Testimony 2009-10-20T04:00:00Z 2009 10 2009-10-20T04:00:00Z   2013-07-27T22:56:12Z   0 0 0900006480a36819
FDA-2009-N-0374-0004 FDA None FDA-2009-N-0374 Andrea Leonard-Segal, MD, "Phase-Out of Chlorofluorocarbon (CFC)-Propelled OTC Epinephrine Metered-Dose Inhalers How to effectively spread the word?" [Public Workshop, September 25, 2009] - Testimony Other TS-Testimony 2009-10-20T04:00:00Z 2009 10 2009-10-20T04:00:00Z   2013-07-27T22:56:09Z   0 0 0900006480a35054
FDA-2009-N-0374-0006 FDA None FDA-2009-N-0374 Leslie Hendeles, Pharm.D., "Asthma, Epinephrine, and Therapeutic Alternatives" [Public Workshop, September 25, 2009] - Testimony Other TS-Testimony 2009-10-20T04:00:00Z 2009 10 2009-10-20T04:00:00Z   2013-07-27T22:56:12Z   0 0 0900006480a36817
FDA-2009-N-0374-0009 FDA None FDA-2009-N-0374 Ruth Parker, MD, "Phase Out of CFC-Propelled Epinephrine Inhalation Aerosol: Communication Challenges" [Public Workshop, September 25, 2009] - Testimony Other TS-Testimony 2009-10-20T04:00:00Z 2009 10 2009-10-20T04:00:00Z   2013-08-11T03:04:30Z   0 0 0900006480a368ad
FDA-2009-N-0374-0005 FDA None FDA-2009-N-0374 Badrul A. Chowdhury, MD, PhD, "Introduction and Background of CFC Propelled Epinephrine Inhalation Aerosol Phase Out" [Public Workshop, September 25, 2009] - Testimony Other TS-Testimony 2009-10-20T04:00:00Z 2009 10 2009-10-20T04:00:00Z   2013-08-11T03:04:29Z   0 0 0900006480a35060
FDA-2009-N-0374-0003 FDA None FDA-2009-N-0374 FDA Public Workshop/Faith Dugan - Agenda Other MM-Memorandum of Meeting 2009-10-08T04:00:00Z 2009 10 2009-10-08T04:00:00Z   2013-07-27T22:55:06Z   0 0 0900006480a291ff
FDA-2009-N-0374-0001 FDA None FDA-2009-N-0374 Educating the Public About Removal of Essential-Use Designation for Epinephrine; Public Workshop; Request for Comments Notice NM-Notice of Meeting 2009-08-20T04:00:00Z 2009 8 2009-08-20T04:00:00Z 2009-11-25T04:59:59Z 2009-08-20T15:27:33Z E9-19985 0 0 0900006480a0e0ba

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;